Overweight & Obesity

Diabetes drug's new weight loss formula fuels cost-benefit debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people—especially ...

Health

Position on medical imaging radiation limits issued

When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by three scientific groups ...

Cardiology

Early rhythm control key in A-fib and heart failure

(HealthDay)—For patients with atrial fibrillation and signs and symptoms of heart failure, early rhythm control (ERC) therapy reduces cardiovascular events, according to a study published online July 30 in Circulation to ...

Surgery

Are robots in surgery better than regular ol' hands?

A review of published research found no clear advantage to surgery with existing robotic platforms, which are costly and increase operation duration. The authors suggest that with refinement, competition, and cost reduction, ...

Medications

FDA defends approval of controversial Alzheimer's drug

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.

Diseases, Conditions, Syndromes

WHO says not to use ivermectin on COVID-19 patients

The World Health Organization said Wednesday that ivermectin—touted by some on social media as a COVID-19 "miracle cure"—should not be used to treat coronavirus patients.

page 9 from 24